Lilly and Lycia Therapeutics Enter into Strategic Collaborat

INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., Aug. 25, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Lycia Therapeutics, Inc. today announced a multi-year research collaboration and licensing agreement

Related Keywords

Molly Mccully , Kevin Hern , Ajay Nirula , Eli Lilly , Carolyn Bertozzi , Liz Melone , Exchange Commission , Lycia Therapeutics Inc , Stanford University , Lycia Therapeutics , Aetna Wun Trombley , Generally Accepted Accounting Principles , South San Francisco , Private Securities Litigation Reform Act , Lilly Media , Lilly Investors , Lycia Media , Nyse Lly , Indiana , Midwest , United States Of America , North America , California , West Southwest , Collaboration , Herapeutics , Conomics , Medicine , Ommerce , Inance , Stock Exchange , Ommercialization , Expectation , Ycia Therapeutics Inc , Research ,